Cullinan Oncology, Inc.

NASDAQ:CGEM

11.6 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -153.162109.195-67.485-59.458-21.654-14.189
Depreciation & Amortization 0.310.0930.0530.0620.070.043
Deferred Income Tax 003.0980.233-0.0040
Stock Based Compensation 30.43827.95724.37514.910.0170
Change In Working Capital -0.33911.176-3.5416.8510.1350.345
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.167-0.509-4.8355.5810.6390.225
Other Working Capital -0.17211.6851.2941.27-0.5040.12
Other Non Cash Items -11.522-275.0850.0677.630.5390.252
Operating Cash Flow -134.275-126.664-43.433-29.772-20.897-13.549
Investing Activities:
Investments In Property Plant And Equipment -0.208-1.133-0.589-0.01-0.02-0.261
Acquisitions Net -0.0362750.9231.4500
Purchases Of Investments -373.383-377.916-525.813-69.763-35.380
Sales Maturities Of Investments 409.397352.933192.03862.90300
Other Investing Activites 0.0360.091-0.334-0.005-0.0350
Investing Cash Flow 35.806248.975-333.775-5.42-35.4-0.261
Financing Activities:
Debt Repayment 1.825-2.20000
Common Stock Issued 38.3880.006267.268145.4585.7150.001
Common Stock Repurchased 0000-0.3780
Dividends Paid 000000
Other Financing Activities 0.538-23.7331.516138.87885.715-0.03
Financing Cash Flow 40.751-25.933268.784140.1485.715-0.029
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -57.71896.378-108.424104.94829.418-13.839
Cash At End Of Period 98.434156.15259.774168.19863.2533.832